HIGHLIGHTS
- who: Constantin N. Baxevanis and collaborators from the , Athens, Greece have published the research work: Combination Immunotherapy in Prostate Cancer, in the Journal: Cancers 2022, 14, 6040. of /2022/
- future: In their review article Fay EK and Graff JN underline the essential role of immunotherapy as one of the most important future directions for the therapeutic treatment 2 of 3 3 of 3
SUMMARY
During the last decade, there has been significant progress in the field of prostate cancer therapeutic treatments based on androgen receptor-axis-targeted therapies, which resulted in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.